Pacific Biosciences of California Inc. (PACB) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pacific Biosciences of Ca...

    NASDAQ: PACB · Real-Time Price · USD
    1.21
    -0.01 (-0.82%)
    At close: Sep 26, 2025, 3:59 PM
    1.22
    0.81%
    After-hours: Sep 26, 2025, 07:33 PM EDT

    Pacific Biosciences of California Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.62 -8.11 -5.85 -22.99
    PEG Ratio
    		 0.25 0.60 -0.1 0.04
    PS Ratio
    		 3.26 12.41 14.32 31.92
    PB Ratio
    		 0.99 3.55 3.26 5.27
    P/FCF Ratio
    		 -2.37 -9.28 -6.56 -35.57
    P/OCF Ratio
    		 -2.44 -9.6 -6.98 -37.47
    OCF/S Ratio
    		 -1.34 -1.29 -2.05 -0.85
    Debt / Equity Ratio
    		 1.33 1.33 1.68 1.21
    Quick Ratio
    		 6.59 7.21 3.04 15.01
    Current Ratio
    		 7.48 7.81 3.24 15.36
    Asset Turnover
    		 0.12 0.11 0.07 0.07
    Interest Coverage
    		 -35.36 -23.32 -20.91 -16.79
    Return on Equity
    		 -0.61 -0.44 -0.56 -0.23
    Return on Assets
    		 -0.25 -0.18 -0.18 -0.09
    Return on Invested Capital
    		 -0.39 -0.19 -0.2 -0.07
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.24 0.26 0.38 0.45
    Net Profit Margin
    		 -2.01 -1.53 -2.45 -1.39
    Pretax Profit Margin
    		 -2.01 -1.59 -2.45 -2.11
    Operating Profit Margin
    		 -3.08 -1.67 -2.39 -1.61
    FCF Margin
    		 -1.38 -1.34 -2.18 -0.9
    EBITDA Margin
    		 -1.58 -1.35 -2.2 -1.92

    Add to Watchlist